Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Gastroenterol. Jan 28, 2020; 26(4): 375-382
Published online Jan 28, 2020. doi: 10.3748/wjg.v26.i4.375

Table 2 Proposed goals of future patient-centered research on neoadjuvant therapy for pancreatic ductal adenocarcinoma

Patient preferences

What are patient perceptions and opinions regarding NT?

What are the barriers and facilitators to NT?

What sources of information inform decision making for NT?

The patient experience

How does shared decision making occur regarding NT?

How do patients perceive communication, coordination, and the health care experience during NT?

What resources are needed by patients undergoing NT?

Patient-reported outcomes (PROs)

Are PROs for pancreatic cancer similar or unique during NT?

How is patient quality of life affected by NT?

Survivorship

Does receipt of NT influence survivorship during and following treatment?

Do patients experience decisional regret/satisfaction?

NT: Neoadjuvant therapy.

Citation: Cloyd JM, Tsung A, Hays J, Wills CE, Bridges JF. Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research. World J Gastroenterol 2020; 26(4): 375-382
URL: https://www.wjgnet.com/1007-9327/full/v26/i4/375.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i4.375

Cloyd JM, Tsung A, Hays J, Wills CE, Bridges JF. Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research. World J Gastroenterol 2020; 26(4): 375-382 [PMID: 32063686 DOI: 10.3748/wjg.v26.i4.375]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.